NDC Pharmacologic Class N0000182150 CD80-directed Antibody Interactions [MoA]
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0003-0371 | Nulojix | Belatacept | Injection, Powder, Lyophilized, For Solution | Intravenous | E.r. Squibb & Sons, L.l.c. | Human Prescription Drug |
There are 1 NDC products with the pharmacologic class CD80-directed Antibody Interactions [MoA].